(Q40816596)

24 September 2017

Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States (English)

1 reference

24 September 2017

1 reference

1 reference

4

Jones RN

1 reference

24 September 2017

1

Pfaller MA

1 reference

24 September 2017

Messer SA

2

1 reference

24 September 2017

Hollis RJ

3

1 reference

24 September 2017

Doern GV

5

1 reference

24 September 2017

Brandt ME

6

1 reference

24 September 2017

Hajjeh RA

7

1 reference

24 September 2017

1 April 1999

1 reference

Diagnostic Microbiology and Infectious Disease

24 September 2017

1 reference

24 September 2017

33

1 reference

24 September 2017

4

1 reference

24 September 2017

217-222

1 reference

The epidemiology of hematogenous candidiasis caused by different Candida species

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Thirteen-year evolution of azole resistance in yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathog

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Resistant candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Resistance of Candida species to fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Importance of Candida species other than C. albicans as pathogens in oncology patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900160-6

7 January 2021

10.1016/S0732-8893(98)00160-6

Identifiers

DOI

1 reference

24 September 2017

1 reference